First AI-Designed Vaccine Passes Human Trial: Cambridge Results Explained
Cambridge University and DIOSynVax completed the first human trial of a vaccine designed entirely by AI simulation. 39 volunteers, no major side effects, immune response confirmed.
·10 min read